[go: up one dir, main page]

MXPA01004963A - Procedimiento para preparar composiciones farmaceuticas en comprimidos de desintegracion rapida sustancialmente exentos de cristales del principio farmacologicaxmente activo provenientes de la modificacion de la estructura cristalina del agente duran - Google Patents

Procedimiento para preparar composiciones farmaceuticas en comprimidos de desintegracion rapida sustancialmente exentos de cristales del principio farmacologicaxmente activo provenientes de la modificacion de la estructura cristalina del agente duran

Info

Publication number
MXPA01004963A
MXPA01004963A MXPA01004963A MXPA01004963A MX PA01004963 A MXPA01004963 A MX PA01004963A MX PA01004963 A MXPA01004963 A MX PA01004963A MX PA01004963 A MXPA01004963 A MX PA01004963A
Authority
MX
Mexico
Prior art keywords
desintegrating
manufacturin
tablets
rapidly
preparation
Prior art date
Application number
Other languages
English (en)
Inventor
Atilio Los Mario
Original Assignee
Bago Sa Labor
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bago Sa Labor filed Critical Bago Sa Labor
Publication of MXPA01004963A publication Critical patent/MXPA01004963A/es
Publication of MX231185B publication Critical patent/MX231185B/es

Links

MXPA01004963 2000-05-19 2001-05-17 Procedimiento para preparar composiciones farmaceuticas en comprimidos de desintegracion rapida sustancialmente exentos de cristales del principio farmacologicaxmente activo provenientes de la modificacion de la estructura cristalina del agente duran MX231185B (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ARP000102442A AR032585A1 (es) 2000-05-19 2000-05-19 Procedimiento para preparar composiciones farmaceuticas en comprimidos de desintegracion rapida sustancialmente exentos de cristales del principio farmacologicamente activo provenientes de la modificacion de la estructura cristalina de dicho agente durante las operaciones de fabricacion de los mismo

Publications (2)

Publication Number Publication Date
MXPA01004963A true MXPA01004963A (es) 2003-08-20
MX231185B MX231185B (es) 2005-10-10

Family

ID=37516292

Family Applications (1)

Application Number Title Priority Date Filing Date
MXPA01004963 MX231185B (es) 2000-05-19 2001-05-17 Procedimiento para preparar composiciones farmaceuticas en comprimidos de desintegracion rapida sustancialmente exentos de cristales del principio farmacologicaxmente activo provenientes de la modificacion de la estructura cristalina del agente duran

Country Status (4)

Country Link
AR (1) AR032585A1 (es)
BR (1) BR0104689A (es)
CL (1) CL2007001675A1 (es)
MX (1) MX231185B (es)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2087893A1 (en) * 2008-02-05 2009-08-12 Laboratorios Bagó S.A. Compositions comprising alprazolam for treating primary insomnia and insomnia associated with anxiety states and processes for preparing them

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2087893A1 (en) * 2008-02-05 2009-08-12 Laboratorios Bagó S.A. Compositions comprising alprazolam for treating primary insomnia and insomnia associated with anxiety states and processes for preparing them
US9308212B2 (en) 2008-02-05 2016-04-12 Laboratorios Bago S.A. Compositions comprising alprazolam for treating primary insomnia and insomnia associated with anxiety states and process for preparing them

Also Published As

Publication number Publication date
CL2007001675A1 (es) 2008-03-07
BR0104689A (pt) 2004-02-25
AR032585A1 (es) 2003-11-19
MX231185B (es) 2005-10-10

Similar Documents

Publication Publication Date Title
HUP0200076A3 (en) C-21 modified epothilones, process for their preparation, pharmaceutical compositions containing them
HUP0300741A3 (en) Bicyclo-pyrazoles active as kinase inhibitors, process for their preparation and pharmaceutical compositions comprising them
HUP0203312A3 (en) Pharmaceutically active sulfonamide derivatives, process for their preparation, and pharmaceutical compositions and their use
HUP0303891A3 (en) Pharmaceutically active piridine derivatives, process for their preparation and pharmaceutical compositions containing them
HUP0301325A3 (en) Stabilized pharmaceutically effective composition and pharmaceutical composition comprising the same and process for preparation the composition
HUP0301187A3 (en) Novel benzyl-piperidine-derivatives, process for their preparation and pharmaceutical compositions containing them
IL150225A0 (en) Lipopeptides, pharmaceutical compositions containing the same and methods for the production thereof
HU0000140D0 (en) Tramadol pharmaceutical compositions, which are retarded agent-releasing, storage-stabiled releasing and process for producing them
MXPA04003027A (es) Metodos para granulacion humeda de azitromicina.
HUP0203060A3 (en) Sustained release complex of a peptide, process for its preparation and pharmaceutical composition containing the same
HUP0302130A3 (en) Combination pharmaceutical compositions and process for their preparation
HUP0201402A3 (en) Bis-sulfonamides, process for their preparation and pharmaceutical compositions containing them
HUP0204202A3 (en) Ibuprofen containing active agent preparation, process for its preparation and pharmaceutical compositions containing it
HUP0202233A3 (en) Derivatives and analogues of galanthamin, their use, pharmaceutical compositions containing them and process for the preparation of them
IL161983A0 (en) Preparation compositions containing acid-unstable physiologically active compounds, and process for producing the same
HUP0100489A3 (en) New piperidine-4-sulphonamide compounds, process for their preparation and pharmaceutical compositions containing them
HUP0302912A3 (en) Betha-thio-amino acids, process for their preparation and pharmaceutical compositions containing them
HUP0302515A3 (en) Sulfanidothienopyrimidines, process for their preparation and pharmaceutical compositions containing them
HUP0204001A3 (en) Substituted aminomethyl-phenyl-cyclohexane derivatives, process for their preparation and pharmaceutical compositions containing them
HUP0102631A3 (en) 1,1- and 1,2-disubstituted cyclopropane derivatives, process for their preparation and pharmaceutical compositions containing them
HUP0303361A3 (en) Substituted 1-aminobutan-3-ol derivatives, process for their preparation and pharmaceutical compositions containing them
AU2002346569A8 (en) Process for the preparation of compositions having an increased amount of pharmaceutically active salts of rotamers
HUP0401829A3 (en) Substituted (1h)-quinoxalin-2-one compounds and substituted 4-aryl- or 4-heteroarylcyclohexane compounds, process for their preparation and pharmaceutical compositions containing the (1h)-quinoxalin-2-one compounds
HUP0300066A3 (en) Polypeptide compounds, process for their preparation and pharmaceutical compositions containing them
MX231185B (es) Procedimiento para preparar composiciones farmaceuticas en comprimidos de desintegracion rapida sustancialmente exentos de cristales del principio farmacologicaxmente activo provenientes de la modificacion de la estructura cristalina del agente duran

Legal Events

Date Code Title Description
FG Grant or registration